GSK Secures EC Approval for Shingrix in a Prefille...
Category : Approval/Launch 8 January 2026GSK has received European Commission (EC) approval for a new prefilled syringe presentation of Shing...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Ascletis Secures FDA IND Clearance for Oral GLP-1...
Category : Clinical Trial Update 8 January 2026Ascletis Pharma has received US FDA Investigational New Drug (IND) clearance to advance ASC30, its o...
Phase III TULIP-SC Trial Confirms Subcutaneous Sap...
Category : Clinical Trial Update 8 January 2026AstraZeneca has reported positive full results from the phase III TULIP-SC trial, showing that subcu...
Oxeia Biopharmaceuticals Launches Equity Crowdfund...
Category : Approval/Launch 8 January 2026Oxeia Biopharmaceuticals has launched an equity crowdfunding campaign on StartEngine to accelerate d...
FDA Grants Priority Review to Tzield for Early Chi...
Category : Clinical Trial Update 7 January 2026The US FDA has moved fast. It has accepted a priority review for Sanofi’s supplemental biologi...
Latest Newsletter Post
-
Oxeia Biopharmaceuticals Launches E..
8 January 2026
-
Phase III TULIP-SC Trial Confirms S..
8 January 2026
-
Ascletis Secures FDA IND Clearance..
8 January 2026
-
GSK Secures EC Approval for Shingri..
8 January 2026
-
Bambusa Therapeutics Doses First Pa..
7 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com